Tag: Clinical trials

news-02072024-102053

GRI Bio Announces Positive Preclinical Data for IPF Treatment

GRI Bio, a biotechnology company based in La Jolla, California, has shared promising preclinical data on its potential treatment for Idiopathic Pulmonary Fibrosis (IPF)....
news-16062024-143317

Mirum Pharmaceuticals Investor Call: Volixibat VANTAGE & VISTAS Studies Analysis Results, June 17, 2024

Mirum Pharmaceuticals, Inc. recently held an investor call to discuss the interim analysis results from two important studies involving the drug Volixibat. The Volixibat...
cell-therapy-market-is-expected-to-reach-a-revenue-of-usd-325-bn-by-2033-at-186-cagr-dimension-market-research

Cell Therapy Market Is Expected To Reach a Revenue Of USD 32.5 Bn By...

Advancements and Projections in the Cell Therapy Market: Insights, Trends, Opportunities, and Recent DevelopmentsThe cell therapy market is projected to reach a revenue of...
moderna-investors-just-got-some-bullish-news

Moderna Investors Just Got Some Bullish News

Moderna's Latest Breakthrough in RSV Vaccine Approval Signals Potential Market GrowthModerna, a well-known biotech company that gained prominence during the development of a successful...
biocryst-presents-new-real-world-evidence-showing-reductions-in-attack-rates-in-hae-patients-with-normal-c1-inhibitor-after-beginning-orladeyo-berotralstat-treatment

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with...

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentIn a recent presentation...
pharming-group-provides-update-on-ongoing-regulatory-review-of-leniolisib-for-the-treatment-of-apds-in-the-european-union

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of...

Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024...

Top News

BREAKING NEWS